HERMELINDA FITTS: Open Payments
NPI 1285164749 · CUERO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 34 payments from 11 companies in 2025. Trend: 2023 $459 · 2024 $455 · 2025 $776
Food & beverage: $776
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $186 |
| AstraZeneca Pharmaceuticals LP | 6 | $148 |
| Novo Nordisk Inc | 8 | $146 |
| PFIZER INC. | 4 | $78 |
| ABBVIE INC. | 3 | $62 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| ACADIA Pharmaceuticals Inc | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Tactile Systems Technology Inc | 1 | $21 |
| Exact Sciences Corporation | 1 | $15 |
Products named: ZEPBOUND, Ozempic, NURTEC ODT, FARXIGA, REXULTI, AIRSUPRA, QULIPTA, BREZTRI.
Industry payments across TX — which companies pay providers there.
